Literature DB >> 2478524

Environmental regulation of expression of virulence determinants in Bordetella pertussis.

A R Melton1, A A Weiss.   

Abstract

The trans-activator vir is required for expression of all virulence-associated genes in Bordetella pertussis. The nature of the global regulation of these factors by vir and environmental signals was examined by Northern blot analysis and with beta-galactosidase transcriptional fusions in five vir-regulated genes. Northern blots suggested that vir regulates at the level of transcription since Vir- organisms did not exhibit detectable mRNA from vir-regulated loci. Environmental signals such as high levels of salts, nicotinic acid, and 6-chloronicotinic acid or growth at low temperatures were examined. Of all of the cations and anions examined, only SO4 ions eliminated transcription of vir-regulated genes and reduced transcription of vir itself, suggesting that global regulation is obtained by modifying expression of the essential component, vir. Organisms grown on 6-chloronicotinic acid or quinaldic acid did not have detectable transcription from vir-regulated loci. Modulation by nicotinic acid, on the other hand, was strain dependent, acting at the level of transcription in strain 18-323 but not in Tohama I derivatives. Growth at lower temperatures reduced, but did not eliminate, transcription from vir-regulated loci. At 28 degrees C the ratio of pertussis toxin mRNA to recA mRNA (a non-vir-regulated factor) was equivalent to that at 37 degrees C, suggesting that transcription at low temperatures is reduced in a proportional manner and need not involve vir.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478524      PMCID: PMC210490          DOI: 10.1128/jb.171.11.6206-6212.1989

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  28 in total

1.  Antigenic modulation of Bordetella pertussis.

Authors:  B W LACEY
Journal:  J Hyg (Lond)       Date:  1960-03

2.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

3.  Genetic studies of the molecular basis of whooping cough.

Authors:  A A Weiss; E L Hewlett; G A Myers; S Falkow
Journal:  Dev Biol Stand       Date:  1985

4.  Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor.

Authors:  P Novotny; A P Chubb; K Cownley; J A Montaraz; J E Beesley
Journal:  Dev Biol Stand       Date:  1985

5.  Effect of pyridines on phenotypic properties of Bordetella pertussis.

Authors:  D R Schneider; C D Parker
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  Genetic analysis of phase change in Bordetella pertussis.

Authors:  A A Weiss; S Falkow
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

8.  Tn5-induced mutations affecting virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett; G A Myers; S Falkow
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

9.  Modulation of Bordetella pertussis by nicotinic acid.

Authors:  W L McPheat; A C Wardlaw; P Novotny
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

10.  Evidence for two functional gal promoters in intact Escherichia coli cells.

Authors:  H Aiba; S Adhya; B de Crombrugghe
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

View more
  55 in total

1.  Antibacterial agents and release of periplasmic pertussis toxin from Bordetella pertussis.

Authors:  K A Craig-Mylius; A A Weiss
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Growth phase influences complement resistance of Bordetella pertussis.

Authors:  Michael G Barnes; Alison A Weiss
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis.

Authors:  D Hot; R Antoine; G Renauld-Mongénie; V Caro; B Hennuy; E Levillain; L Huot; G Wittmann; D Poncet; F Jacob-Dubuisson; C Guyard; F Rimlinger; L Aujame; E Godfroid; N Guiso; M-J Quentin-Millet; Y Lemoine; C Locht
Journal:  Mol Genet Genomics       Date:  2003-05-24       Impact factor: 3.291

4.  Temporal expression of pertussis toxin and Ptl secretion proteins by Bordetella pertussis.

Authors:  Amy A Rambow-Larsen; Alison A Weiss
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

5.  Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis.

Authors:  D Martin; M S Peppler; B R Brodeur
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

6.  Identification of Bordetella pertussis regulatory sequences required for transcriptional activation of the fhaB gene and autoregulation of the bvgAS operon.

Authors:  C R Roy; S Falkow
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

7.  Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis.

Authors:  S Stibitz; M S Yang
Journal:  J Bacteriol       Date:  1991-07       Impact factor: 3.490

8.  Modulation of adenylate cyclase toxin production as Bordetella pertussis enters human macrophages.

Authors:  H R Masure
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

9.  A modified two-component regulatory system is involved in temperature-dependent biosynthesis of the Pseudomonas syringae phytotoxin coronatine.

Authors:  M Ullrich; A Peñaloza-Vázquez; A M Bailey; C L Bender
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

10.  BvgAS is sufficient for activation of the Bordetella pertussis ptx locus in Escherichia coli.

Authors:  M A Uhl; J F Miller
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.